LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,662,257 | -3.1% | 590,470 | -0.4% | 0.02% | 0.0% |
| Q2 2023 | $40,935,825 | +60.3% | 593,015 | +12.0% | 0.02% | +64.3% |
| Q1 2023 | $25,537,842 | +0.6% | 529,611 | +4.1% | 0.01% | -12.5% |
| Q4 2022 | $25,380,951 | +23.8% | 508,589 | +1.1% | 0.02% | +14.3% |
| Q3 2022 | $20,501,497 | -25.2% | 503,010 | +0.9% | 0.01% | -26.3% |
| Q2 2022 | $27,391,030 | +60.0% | 498,282 | +5.8% | 0.02% | +72.7% |
| Q1 2022 | $17,116,213 | +42.4% | 471,002 | +88.5% | 0.01% | +57.1% |
| Q4 2021 | $12,022,000 | -27.8% | 249,868 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $16,653,000 | +23.2% | 329,368 | 0.0% | 0.01% | +27.3% |
| Q2 2021 | $13,521,000 | +41.5% | 329,368 | 0.0% | 0.01% | +37.5% |
| Q1 2021 | $9,558,000 | – | 329,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |